Hansen Pharmaceutical (002412)
Hunan Hansen Pharmaceutical Co., Ltd. engages in the production and sale of traditional Chinese preparations in China and internationally. The company offers me...
- Open
- 10.19
- High
- 10.19
- Low
- 10.19
- Prev. Close
- 9.26
- Volume
- 225.25K
- Turnover
- 229.53M
- Avg Price
- 10.19
- Bid/Ask Ratio
- 99.52%
- Amplitude
- 0.00%
- 52wk High
- 10.19
- Volume Ratio
- 0.64
- Turnover Ratio
- 4.48%
Hansen Pharmaceutical Analyst Rating
View moreForecast & Rating
Mar 2, 2020Price forecast
¥15.9056.04%
Forecast & RatingBuy
1analysts
- Strong buy0.00%
- Buy100.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Wallstreetcn · Feb 5 at 09:30 PM
February 6th Midday Review: ChiNext opened lower but rose to gain 0.65%, with chemical and robotics concept stocks collectively strengthening
- Zhitong · Oct 27, 2025 at 05:12 AM
Hansen Pharmaceutical: The net profit for the third quarter was 13.9868 million yuan, a year-on-year decrease of 53.78%
- Zhitong · Aug 25, 2025 at 05:44 AM
Hansen Pharmaceutical released its performance for the first half of the year, with a net profit attributable to the parent company of 68.5384 million yuan, a decrease of 31.80%
- Zhitong · Aug 24, 2025 at 08:52 PM
The A-share traditional Chinese medicine sector rapidly surged, with Xintian Pharma hitting the limit up, and YIBAI PHARMACEUTICAL, Zhendong Pharmacy, ZHONGSHENGYAOYE, Hansen Pharmaceutical, and ENWEI PHARMACEUTICAL following suit
- Zhitong · Apr 25, 2025 at 09:21 AM
Hansen Pharmaceutical released its first-quarter performance, with a net profit attributable to the parent company of 11.2572 million yuan, a year-on-year decrease of 80.68%
- Zhitong · Apr 25, 2025 at 06:40 AM
Hansen Pharmaceutical: Net profit of 220 million yuan in 2024, a year-on-year increase of 7.43%
